Swiss American CDMO Partners with BioNTX to Launch Biotech Alliance

-Swiss American CDMO and BioNTX have partnered to host the inaugural Biotechnology and Healthcare Industry Alliance of North Texas (BHIANT) launch meeting ...

June 15, 2023 | Thursday | News
Future Fields and Jenthera Therapeutics Collaborate on Novel Cancer Biologics Delivery Protein

Future Fields, a pioneering biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protei...

June 14, 2023 | Wednesday | News
Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China

The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial1 is being led by Lanhzou Biotechnique Development  wi...

June 13, 2023 | Tuesday | News
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe

SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and supp...

June 13, 2023 | Tuesday | News
Salipro Biotech Expands Global Intellectual Property Portfolio with Granted Patent in Japan

Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, is delighted to an...

June 13, 2023 | Tuesday | News
Annexus Health Partners with Omega Healthcare

Annexus Health, Inc., the leading healthcare technology company that is revolutionizing the patient access journey through its innovative solutions, today ...

June 12, 2023 | Monday | News
Aviko Radiopharmaceuticals and Neutron Therapeutics Join Forces for Boron Neutron Capture Therapy Advancement

Aviko Radiopharmaceuticals, a Deerfield Management-founded biotechnology company developing medicines to unlock the potential of boron neutron capture ther...

June 09, 2023 | Friday | News
BetaLife wins Cytiva’s first BioChallenge Competition in Southeast Asia

BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes in Southeast Asia. Cytiva’s BioChall...

June 08, 2023 | Thursday | News
Agilent Announces Full Workflow for US EPA Method 1633 for Targeted PFAS Analysis

Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated, complete workflow solution for targeted per- and polyfluoroalkyl substances (PFAS...

June 07, 2023 | Wednesday | News
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics

Clinically validated lipid nanoparticle (LNP) delivery technology will further strengthen Bayer’s gene therapy portfolio High potency ionizable li...

June 07, 2023 | Wednesday | News
Agilent Announces Inspirational LC/TQ and LC/Q-TOF Mass Spectrometry Solutions

The superior Agilent 6495 Triple Quadrupole LC/MS (LC/TQ) System is ideal for demanding and challenging targeted analysis applications requiring the highes...

June 06, 2023 | Tuesday | News
Thermo Fisher Scientific Showcases Solutions for Accelerating Biological Discovery

Thermo Fisher Scientific is showcasing new mass spectrometry and chromatography instruments, software and workflows that enable customers to unlock deeper ...

June 06, 2023 | Tuesday | News
Sirnaomics Initiates Phase I Study of RNAi Therapeutic STP122G for Anticoagulant Treatment

STP122G is part of the Group's GalAhead™ Factor XI RNAi therapeutic program, which has applications across a broad range of disease indications such ...

June 02, 2023 | Friday | News
Illumina unveils AI software to predict disease-causing genetic mutations in patients

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the new PrimateAI-3D, an artificial intellige...

June 02, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close